An Bang Lu
Förmögenhet: 13 M $ per 2026-07-31
Förmögenhet: 13 M $ per 2026-07-31
An Bang Lu is currently Chief Executive Officer & Executive Director at VISEN Pharmaceuticals (Shanghai) Co., Ltd. and Chief Executive Officer & Executive Director at VISEN Pharmaceuticals since 2021.
Formerly, Mr. Lu was President, General Manager & Head-Greater China at Takeda Pharmaceutical Co., Ltd. from 2010 to 2014.
Education includes an undergraduate degree from Taipei Medical University, conferred in 1989.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
VISEN PHARMACEUTICALS 4,68 % | 2026-01-01 | 5 326 250 ( 4,68 % ) | 13 M $ | 2026-07-31 |
| Företag | Position | Start |
|---|---|---|
| VISEN PHARMACEUTICALS | Verkställande Direktör | 2018-11-07 |
VISEN Pharmaceuticals (Shanghai) Co., Ltd.
VISEN Pharmaceuticals (Shanghai) Co., Ltd. BiotechnologyHealth Technology Develops endocrine disease therapies | Verkställande Direktör | - |
| Företag | Position | Slut |
|---|---|---|
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | President | 2014-01-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
Takeda Pharmaceutical Co., Ltd.
Takeda Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, manufacturing and marketing of pharmaceutical products | Health Technology |
Taipei Medical University
Taipei Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
VISEN Pharmaceuticals (Shanghai) Co., Ltd.
VISEN Pharmaceuticals (Shanghai) Co., Ltd. BiotechnologyHealth Technology Develops endocrine disease therapies | Health Technology |
VISEN Pharmaceuticals
VISEN Pharmaceuticals Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes paradigm-shifting endocrine therapies | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån